Study of an experimental drug for recovery after severe stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests an experimental drug given by IV to help people recover arm and leg movement after a severe stroke. It may help improve recovery in the early weeks after a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 80 years old.
- You had a stroke caused by a blocked blood vessel (ischemic stroke) that caused moderate to severe weakness on one side of your body.
- You were independent in daily activities before the stroke (did not need nursing care).
- You can follow instructions and cooperate during the study.
- You have not had major surgery or a serious injury in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called HRS-4029 for people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help improve recovery when given very soon after the stroke starts.
This trial tests a clot-busting drug called tenecteplase given later than usual (4.5 to 9 hours after stroke symptoms) to people whose MRI shows the stroke may still be reversible. The goal is to see if it helps reduce disability after a stroke.
This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.
This study tests a new medicine made from tiny particles (neural exosomes) that may help the brain recover after a severe stroke. It is for people who had a large blood clot removed but still have significant disability shortly after the stroke.
This study tests whether an investigational treatment can protect brain cells in people who recently had an ischemic stroke (a blockage in a brain artery). The goal is to see if the treatment improves recovery and reduces long-term disability.
This trial tests if TAK-755 can help people who have had a moderate to severe stroke within the last 24 hours. It aims to see if the drug can improve recovery by protecting brain tissue that is still salvageable.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.